HK1209041A1 - A method of weight reduction - Google Patents
A method of weight reduction Download PDFInfo
- Publication number
- HK1209041A1 HK1209041A1 HK15109728.3A HK15109728A HK1209041A1 HK 1209041 A1 HK1209041 A1 HK 1209041A1 HK 15109728 A HK15109728 A HK 15109728A HK 1209041 A1 HK1209041 A1 HK 1209041A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- present disclosure
- weight reduction
- reduction
- methazolamide
- hyperglycaemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651335P | 2012-05-24 | 2012-05-24 | |
| US201261651335P | 2012-05-24 | ||
| PCT/AU2013/000259 WO2013173858A1 (en) | 2012-05-24 | 2013-03-15 | A method of weight reduction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1209041A1 true HK1209041A1 (en) | 2016-03-24 |
Family
ID=49622926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15109728.3A HK1209041A1 (en) | 2012-05-24 | 2013-03-15 | A method of weight reduction |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150174108A1 (enExample) |
| EP (1) | EP2854806A4 (enExample) |
| JP (1) | JP6438389B2 (enExample) |
| KR (1) | KR20150023404A (enExample) |
| CN (1) | CN104582701B (enExample) |
| AU (1) | AU2013202981B2 (enExample) |
| BR (1) | BR112014029302A2 (enExample) |
| CA (1) | CA2874512A1 (enExample) |
| CO (1) | CO7160083A2 (enExample) |
| HK (1) | HK1209041A1 (enExample) |
| MX (1) | MX2014014316A (enExample) |
| NZ (1) | NZ702666A (enExample) |
| RU (1) | RU2664442C2 (enExample) |
| SG (1) | SG11201407786XA (enExample) |
| WO (1) | WO2013173858A1 (enExample) |
| ZA (1) | ZA201408703B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2106260B8 (en) | 2007-01-25 | 2018-04-04 | Naia Metabolic, Inc. | Insulin sensitisers and methods of treatment |
| SG10201705388XA (en) * | 2012-05-24 | 2017-07-28 | Verva Pharmaceuticals Ltd | A Method Of Improving Liver Function |
| US10039752B2 (en) * | 2016-07-21 | 2018-08-07 | Cipla Limited | Methazolamide for the treatment of cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2783241A (en) * | 1957-02-26 | S-acylimino-x-substituted-az-i | ||
| JP2000080047A (ja) * | 1998-06-30 | 2000-03-21 | Takeda Chem Ind Ltd | 医 薬 |
| US6946243B2 (en) * | 2000-07-20 | 2005-09-20 | Solvay Pharmaceuticals Gmbh | Method of identifying compounds suitable for treatment and/or prophylaxis of obesity |
| AU2001280093A1 (en) * | 2000-08-11 | 2002-02-25 | Einar Stefansson | Method for the prevention and treatment of retinopathy |
| PL377614A1 (pl) * | 2003-03-18 | 2006-02-06 | Novartis Ag | Kompozycje zawierające kwasy tłuszczowe i aminokwasy |
| ES2639579T3 (es) * | 2003-04-29 | 2017-10-27 | Orexigen Therapeutics, Inc. | Composiciones para afectar la pérdida de peso que comprende un antagonista opioide y bupropión |
| TW200526678A (en) | 2003-08-01 | 2005-08-16 | Janssen Pharmaceutica Nv | Substituted indole-O-glucosides |
| WO2007114948A2 (en) * | 2006-04-04 | 2007-10-11 | The Brigham And Women's Hospital, Inc. | Methods and compositions for inhibiting cell death |
| EP2106260B8 (en) * | 2007-01-25 | 2018-04-04 | Naia Metabolic, Inc. | Insulin sensitisers and methods of treatment |
| WO2011002011A1 (ja) * | 2009-07-01 | 2011-01-06 | キッセイ薬品工業株式会社 | Sglt1阻害薬とdpp-iv阻害薬を組み合わせてなる医薬 |
| EP3459558B1 (en) * | 2010-06-25 | 2020-07-29 | Aston University | Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| WO2012008549A1 (ja) * | 2010-07-15 | 2012-01-19 | 武田薬品工業株式会社 | 複素環化合物 |
| SG10201705388XA (en) * | 2012-05-24 | 2017-07-28 | Verva Pharmaceuticals Ltd | A Method Of Improving Liver Function |
-
2013
- 2013-03-15 MX MX2014014316A patent/MX2014014316A/es unknown
- 2013-03-15 EP EP13794519.2A patent/EP2854806A4/en not_active Withdrawn
- 2013-03-15 WO PCT/AU2013/000259 patent/WO2013173858A1/en not_active Ceased
- 2013-03-15 BR BR112014029302A patent/BR112014029302A2/pt not_active Application Discontinuation
- 2013-03-15 SG SG11201407786XA patent/SG11201407786XA/en unknown
- 2013-03-15 AU AU2013202981A patent/AU2013202981B2/en not_active Ceased
- 2013-03-15 JP JP2015512967A patent/JP6438389B2/ja not_active Expired - Fee Related
- 2013-03-15 HK HK15109728.3A patent/HK1209041A1/xx unknown
- 2013-03-15 CA CA2874512A patent/CA2874512A1/en not_active Abandoned
- 2013-03-15 CN CN201380033658.6A patent/CN104582701B/zh not_active Expired - Fee Related
- 2013-03-15 RU RU2014150946A patent/RU2664442C2/ru not_active IP Right Cessation
- 2013-03-15 KR KR20147035499A patent/KR20150023404A/ko not_active Withdrawn
- 2013-03-15 NZ NZ702666A patent/NZ702666A/en not_active IP Right Cessation
- 2013-03-15 US US14/403,495 patent/US20150174108A1/en not_active Abandoned
-
2014
- 2014-11-26 ZA ZA2014/08703A patent/ZA201408703B/en unknown
- 2014-12-19 CO CO14279766A patent/CO7160083A2/es unknown
-
2018
- 2018-02-09 US US15/892,989 patent/US20180333398A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150174108A1 (en) | 2015-06-25 |
| BR112014029302A2 (pt) | 2017-06-27 |
| KR20150023404A (ko) | 2015-03-05 |
| EP2854806A4 (en) | 2015-11-18 |
| ZA201408703B (en) | 2018-07-25 |
| AU2013202981B2 (en) | 2014-11-13 |
| WO2013173858A1 (en) | 2013-11-28 |
| CO7160083A2 (es) | 2015-01-15 |
| JP6438389B2 (ja) | 2018-12-12 |
| CA2874512A1 (en) | 2013-11-28 |
| JP2015520759A (ja) | 2015-07-23 |
| CN104582701A (zh) | 2015-04-29 |
| CN104582701B (zh) | 2018-01-16 |
| RU2014150946A (ru) | 2016-07-10 |
| US20180333398A1 (en) | 2018-11-22 |
| EP2854806A1 (en) | 2015-04-08 |
| RU2664442C2 (ru) | 2018-08-17 |
| AU2013202981A1 (en) | 2013-12-12 |
| MX2014014316A (es) | 2015-07-06 |
| SG11201407786XA (en) | 2015-03-30 |
| NZ702666A (en) | 2016-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201503110B (en) | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level | |
| WO2013169864A3 (en) | TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE | |
| WO2013173129A3 (en) | Treatment of amd using aav sflt-1 | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| WO2010018217A3 (en) | Purin derivatives for use in the treatment of fab-related diseases | |
| WO2012062925A3 (en) | Compounds and methods for treating pain | |
| BR112013021125A2 (pt) | método para regular os níveis de glicose no sangue, método para aumentar a secreção da insulina ou promover a liberação da insulina na corrente sanguínea, método para tratar uma doença ou condição, método para retardar o ínicio de uma doença ou condição de doença kit, composto de composição farmacêutica | |
| HK1211231A1 (en) | Exendin-4 derivatives | |
| WO2009065406A3 (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases | |
| WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
| HK1198869A1 (en) | Combination treatments for hepatitis c | |
| WO2012149157A3 (en) | Heterocyclic compounds for the inhibition of pask | |
| WO2010014690A3 (en) | Medical devices for therapeutic agent delivery | |
| WO2010151755A3 (en) | TREATMENT OF INFLAMMATORY DISEASES USING miR-124 | |
| EA201490378A1 (ru) | ЛЕЧЕНИЕ РАССЕЯННОГО СКЛЕРОЗА С ИСПОЛЬЗОВАНИЕМ КОМБИНАЦИИ ЛАХИНИМОДА И ИНТЕРФЕРОНА-β | |
| WO2013041519A9 (en) | Ror gamma modulators | |
| WO2012023623A3 (ja) | ハンター症候群の治療剤 | |
| EA201290603A1 (ru) | Способ лечения | |
| WO2012094462A3 (en) | Heterocyclic compounds for the inhibition of pask | |
| WO2009045543A8 (en) | Treatment of conditions related to shock | |
| WO2012131001A3 (en) | Cushion for patient interface | |
| WO2013109342A8 (en) | Method of treating diabetes using non-glycosylated apolipoprotein a-iv | |
| MX347620B (es) | Derivados de sulfonilaminopirrolidinona, su preparacion y aplicacion terapeutica. | |
| EP2106260A4 (en) | INSULIN SENSITIZERS AND TREATMENT PROCEDURES THEREWITH | |
| WO2012092305A3 (en) | Nanonized iron compositions and methods of use thereof |